MiMedx Group, Inc short interest in 2025
In 2025, MiMedx Group, Inc's disclosed short interest ran from 3.04% of shares outstanding on 15 Jan 2025 to 3.63% on 31 Dec 2025, a change of +0.59 percentage points. The year's high was 3.74% on 15 Jul 2025 and its low 2.53% on 14 Feb 2025, averaging 3.21% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.39 days on 15 Sep 2025. Full history: MiMedx Group, Inc.
Cite this page
By year: 2018 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 3.04% (15 Jan 2025)
- End of year
- 3.63% (31 Dec 2025)
- Change
- +0.59 pp
- High
- 3.74% (15 Jul 2025)
- Low
- 2.53% (14 Feb 2025)
- Average
- 3.21%
- Highest days to cover
- 11.39 (15 Sep 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 3.04% | 6.34 | |
| 31 Jan 2025 | 2.63% | 6.92 | |
| 14 Feb 2025 | 2.53% | 8.24 | |
| 28 Feb 2025 | 2.78% | 6.78 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 2.82% | 6.51 | |
| 31 Mar 2025 | 3.20% | 9.21 | |
| 15 Apr 2025 | 3.28% | 7.92 | |
| 30 Apr 2025 | 3.24% | 10.32 | 10-Q filed, results (8-K) |
| 15 May 2025 | 3.62% | 4.67 | |
| 30 May 2025 | 3.51% | 9.03 | |
| 13 Jun 2025 | 3.38% | 9.65 | |
| 30 Jun 2025 | 3.61% | 7.43 | |
| 15 Jul 2025 | 3.74% | 5.56 | |
| 31 Jul 2025 | 3.38% | 5.07 | 10-Q filed, results (8-K) |
| 15 Aug 2025 | 3.40% | 6.69 | |
| 29 Aug 2025 | 3.36% | 11.21 | |
| 15 Sep 2025 | 3.21% | 11.39 | |
| 30 Sep 2025 | 3.19% | 7.17 | |
| 15 Oct 2025 | 3.25% | 6.48 | |
| 31 Oct 2025 | 3.02% | 4.02 | 10-Q filed, results (8-K) |
| 14 Nov 2025 | 3.16% | 4.51 | |
| 28 Nov 2025 | 3.00% | 5.80 | |
| 15 Dec 2025 | 3.11% | 5.92 | |
| 31 Dec 2025 | 3.63% | 6.94 |
See also: MiMedx Group, Inc's full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.